慢性喘息性支气管炎采用硫酸镁治疗的效果分析.docVIP

精品论文 参考文献 慢性喘息性支气管炎采用硫酸镁治疗的效果分析 钟莉 　　威远县第二人民医院 四川内江 642450 　　摘要：目的：探讨硫酸镁治疗慢性喘息性支气管炎的临床疗效。方法：选取我院在2014年2月至2015年2月收治的86例慢性喘息性支气管炎患者作为研究对象，使用随机数字表法分为治疗组和对照组（各43例），对照组患者实施祛痰、吸氧、抗感染等常规治疗，治疗组在对照组基础上加用硫酸镁，比较两组患者的症状缓解时间、临床疗效及不良反应发生率。结果：治疗组的喘鸣音、咳嗽、咳痰、喘憋消失时间均显著短于对照组，Plt;0.05；治疗组的显效率为55.81%，显著高于对照组的37.21%，治疗组的治疗总有效率为90.70%，显著高于对照组的79.07%，Plt;0.05；两组患者的不良反应发生率比较无统计学意义（Pgt;0.05）。结论：硫酸镁辅助治疗慢性喘息性支气管炎，能迅速改善喘憋、喘鸣音、咳嗽等临床症状，提高临床疗效，并且不良反应较小，值得推广。 　　关键词：硫酸镁；慢性喘息性支气管炎；临床疗效 　　[Abstract]Objective：To evaluate the clinical efficacy of magnesium sulfate treatment of chronic asthmatic bronchitis.Methods：In our hospital from February 2014 to February 2015 were treated 86 cases of chronic asthmatic bronchitis patients as research subjects，divided into the treatment group and the control group（43 patients）using a random number table，patients in the control group implementation expectorant，oxygen，antibiotics and other conventional treatment group were based on the use of magnesium sulfate，symptoms remission time two groups were compared，the clinical efficacy and incidence of adverse reactions.Results：The treatment group wheezing，cough，sputum，wheezing disappearance time was significantly shorter than the control group，P lt;0.05；effective in the treatment group was 55.81%，significantly higher than the 37.21 percent，the treatment group The total effective rate was 90.70%，significantly higher than the 79.07%，P lt;0.05；incidence of adverse reactions of the two groups was not statistically significant（Pgt; 0.05）.Conclusion：magnesium sulfate adjuvant treatment of chronic asthmatic bronchitis，can rapidly improve wheezing，wheezing sound clinical symptoms，such as cough，improve the clinical efficacy and adverse reactions is small，it is worth promoting. 　　[Key words]magnesium sulfate；chronic asthmatic bronchitis；clinical efficacy 　　慢性喘息性支气管炎是临床常见的呼吸系统疾病，随着自然生态系统破坏的日益加重，空气质量不断恶化，本病的临床发病率也呈现出了明显的上升趋势，严重危害着人们的生理健康及日常生活[1]。目前，临床治疗慢性喘息性支气管炎仍以药物保守治疗为主，我院在慢性喘息性支气管炎的临床治疗中，应用了硫酸镁，并取得了较好的效果，现报道如下。 　　1 一般资料与方法 　　1.1